Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 22112000)

1.

Outcomes of Pneumocystis jiroveci pneumonia infections in pediatric heart transplant recipients.

Ng B, Dipchand A, Naftel D, Rusconi P, Boyle G, Zaoutis T, Edens RE.

Pediatr Transplant. 2011 Dec;15(8):844-8. doi: 10.1111/j.1399-3046.2011.01589.x.

2.

IV pentamidine for primary PJP prophylaxis in adults undergoing allogeneic hematopoietic progenitor cell transplant.

Lim MJ, Stebbings A, Lim SJ, Foor K, Hou JZ, Farah R, Raptis A, Marks S, Weber D, Im A, Dorritie K, Sehgal A, Agha M, Lim SH.

Bone Marrow Transplant. 2015 Jun 8. doi: 10.1038/bmt.2015.131. [Epub ahead of print] No abstract available.

PMID:
26052915
3.

Granulomatous PJP presenting as a solitary lung nodule in an immune competent female.

Lam J, Kelly MM, Leigh R, Parkins MD.

Respir Med Case Rep. 2013 Oct 26;11:4-6. doi: 10.1016/j.rmcr.2013.10.002. eCollection 2014.

4.

Pneumocystis jiroveci prophylaxis in patients undergoing Bendamustine treatment: the need for a standardized protocol.

Abkur TM, Saeed M, Ahmed SZ, McArthur R, Leahy M, O'Leary H, O'Keeffe D.

Clin Case Rep. 2015 Apr;3(4):255-9. doi: 10.1002/ccr3.195. Epub 2015 Feb 9.

5.

Clinical Usefulness of HRCT in Assessing the Severity of Pneumocystis jirovecii Pneumonia: A Cross-sectional Study.

Chou CW, Chao HS, Lin FC, Tsai HC, Yuan WH, Chang SC.

Medicine (Baltimore). 2015 Apr;94(16):e768. doi: 10.1097/MD.0000000000000768.

PMID:
25906111
6.

International pediatric transplant association.

[No authors listed]

Pediatr Transplant. 2015 May;19 Suppl 1:1-17. doi: 10.1111/petr.12457. No abstract available.

PMID:
25800280
7.

Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS?

Liebling M, Rubio E, Ie S.

Expert Rev Respir Med. 2015 Apr;9(2):171-81. doi: 10.1586/17476348.2015.1002471.

PMID:
25771943
8.

Single nodular opacity of granulomatous pneumocystis jirovecii pneumonia in an asymptomatic lymphoma patient.

Kim HS, Shin KE, Lee JH.

Korean J Radiol. 2015 Mar-Apr;16(2):440-3. doi: 10.3348/kjr.2015.16.2.440. Epub 2015 Feb 27.

9.

Pneumocystis jirovecci pneumonia in connective tissue diseases: Comparison with other immunocompromised patients.

Teichtahl AJ, Morrisroe K, Ciciriello S, Jennens I, Tadros S, Wicks I.

Semin Arthritis Rheum. 2015 Jan 29. pii: S0049-0172(15)00008-6. doi: 10.1016/j.semarthrit.2015.01.007. [Epub ahead of print]

PMID:
25708837
10.

Pneumocystis jirovecii pneumonia in liver transplant recipients: a systematic review.

Kostakis ID, Sotiropoulos GC, Kouraklis G.

Transplant Proc. 2014 Nov;46(9):3206-8. doi: 10.1016/j.transproceed.2014.09.156.

PMID:
25420860
11.

The impact of concomitant pulmonary infection on immune dysregulation in Pneumocystis jirovecii pneumonia.

Chou CW, Lin FC, Tsai HC, Chang SC.

BMC Pulm Med. 2014 Nov 19;14:182. doi: 10.1186/1471-2466-14-182.

12.

UK survey of Pneumocystis jirovecii pneumonia (PJP) prophylaxis use in paediatric oncology patients.

Proudfoot R, Cox R, Phillips B, Wilne S.

Arch Dis Child. 2015 Jan;100(1):115. doi: 10.1136/archdischild-2014-307515. Epub 2014 Oct 16. No abstract available.

PMID:
25324566
13.

Pneumocystis jiroveci outbreak in a renal transplant center: Lessons learnt.

Jairam A, Dassi M, Chandola P, Lall M, Mukherjee D, Hooda AK.

Indian J Nephrol. 2014 Sep;24(5):276-9. doi: 10.4103/0971-4065.132987.

14.

Outbreak of Pneumocystis jirovecii pneumonia in renal transplant recipients on prophylaxis: our observation and experience.

Chandola P, Lall M, Sen S, Bharadwaj R.

Indian J Med Microbiol. 2014 Jul-Sep;32(3):333-6. doi: 10.4103/0255-0857.136594.

15.

Pneumocystis jiroveci pneumonitis complicating ruxolitinib therapy.

Lee SC, Feenstra J, Georghiou PR.

BMJ Case Rep. 2014 Jun 2;2014. pii: bcr2014204950. doi: 10.1136/bcr-2014-204950.

PMID:
24891492
16.

Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxis.

Lingaratnam SM, Slavin MA, Thursky KA, Teh BW, Haeusler GM, Seymour JF, Rischin D, Worth LJ.

Leuk Lymphoma. 2015 Jan;56(1):157-62. doi: 10.3109/10428194.2014.911861.

PMID:
24717111
17.

Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients.

Roux A, Gonzalez F, Roux M, Mehrad M, Menotti J, Zahar JR, Tadros VX, Azoulay E, Brillet PY, Vincent F; Groupe de recherche respiratoire en réanimation en onco-hématologie (Grrr-OH).

Med Mal Infect. 2014 May;44(5):185-98. doi: 10.1016/j.medmal.2014.01.007. Epub 2014 Mar 11. Review.

PMID:
24630595
18.

Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: clinical significance of quantitative polymerase chain reaction.

Teh BW, Azzato FA, Lingaratnam SM, Thursky KA, Slavin MA, Worth LJ.

Med Mycol. 2014 May;52(4):427-32. doi: 10.1093/mmy/myt020. Epub 2014 Feb 28.

PMID:
24625674
19.

Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.

Tu GW, Ju MJ, Xu M, Rong RM, He YZ, Xue ZG, Zhu TY, Luo Z.

Nephrology (Carlton). 2013 Nov;18(11):736-42. doi: 10.1111/nep.12133. Review.

PMID:
24571744
20.

Mortality and morbidity after retransplantation after primary heart transplant in childhood: an analysis from the registry of the International Society for Heart and Lung Transplantation.

Conway J, Manlhiot C, Kirk R, Edwards LB, McCrindle BW, Dipchand AI.

J Heart Lung Transplant. 2014 Mar;33(3):241-51. doi: 10.1016/j.healun.2013.11.006. Epub 2013 Nov 28.

PMID:
24462559
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk